129 results
Page 3 of 7
8-K
EX-10.3
fnwwh c7u38i822e0bx7
20 Nov 15
Galectin Therapeutics Announces Pricing of $9.8 Million
12:00am
8-K
EX-10.1
vum6u8gxbtpdr7
12 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hrqqf9ke7ckyt6yicuy2
12 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
nzs u1ym1igkf3q7
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
m5ubnglv
21 Sep 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
px1a61y06p07
25 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
0v6k4 v060i59in
1 May 12
Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs
12:00am
8-K
EX-10.1
dzslk7y2ocdtcn0q
5 Mar 12
Appoints Thomas A. Mcgauley As Acting Chief Financial Officer and Extends Term of Employment of Maureen E. Foley As Chief Operating Officer
12:00am
8-K
EX-10.2
13025f
20 Dec 11
Other Events
12:00am
8-K
EX-10.1
xzpy9hu3rflkmp6odu
5 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
k7kf7zz
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-10.1
d23k6qgmf0l
28 Apr 11
Entry into a Material Definitive Agreement
12:00am